Buy

Kirloskar Oil Engines Ltd. (KOEL) posted healthy financial performance in Q1FY26. Power Gen (PG) segment clocked in 15% YoY growth to come in at Rs 6.1bn owing to sales volumes returning back to normalcy and healthy growth in the HHP segment. The LHP and MHP segment which is the mainstay of KOEL witnessed volumes normalizing back to the pre CPCB IV+ period. Demand trends stay positive with infrastructure verticals such as residential and commercial realty exhibiting good demand. Demand also continues to be broad based across various infrastructure verticals. The management wants to focus actively on...

We maintain a BUY rating on Fortis Healthcare with a target price of Rs 1,000/share.

We maintain a BUY rating with a 16% upside potential.

We maintain our BUY recommendation on the stock.

We maintain our BUY rating on the stock with a target price of Rs 830/share,

We maintain our BUY recommendation on the stock.

We maintain our BUY recommendation for the stock.

We maintain a BUY rating on the stock with a target price of Rs 13,840/share, offering an upside potential of 13% from the CMP.

Emami’s Q1FY26 performance beat estimates on all fronts, despite a weak summer which hit revenue growth of summer-centric portfolio.

Q1FY26 standalone revenue of Rs. 9,928 crore was down 1.4 y-o-y due to 90% mix of RTM projects in transmission revenue.